Author:
Saito Minoru,Kimoto Masafumi,Araki Teruo,Shimada Yukie,Fujii Ryoji,Oofusa Ken,Hide Michihiro,Usui Tsuguru,Yoshizato Katsutoshi
Funder
Japan Science and Technology Corporation
Reference19 articles.
1. Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer;Sarosdy;J Urol,1995
2. Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment;Soloway;J Urol,1996
3. Urinary fibronectin fragments (a potential tumor marker) measured by immunoenzymometric assay with domain-specific monoclonal antibodies;Katayama;Clin Chem,1991
4. Evaluation of two new urinary tumor markers: bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder cancer;Sanchez-Carbayo;Clin Cancer Res,2000
5. A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer;Schmetter;J Urol,1997
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献